These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3792445)

  • 1. Enhancement of canine coronary collateral flow by nafazatrom.
    Fiedler VB; Mardin M
    Eur J Pharmacol; 1986 Nov; 130(3):157-67. PubMed ID: 3792445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury.
    Fiedler VB; Mardin M; Perzborn E; Grützmann R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):267-74. PubMed ID: 3841382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.
    Fiedler VB
    Basic Res Cardiol; 1983; 78(3):266-80. PubMed ID: 6615399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of nafazatrom on ischemic reperfused myocardium.
    Shea MJ; Murtagh JJ; Jolly SR; Abrams GD; Pitt B; Lucchesi BR
    Eur J Pharmacol; 1984 Jun; 102(1):63-70. PubMed ID: 6479219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nafazatrom and indomethacin on experimental myocardial ischemia in the anesthetized dog.
    Fiedler VB; Mardin M
    J Cardiovasc Pharmacol; 1985; 7(5):983-9. PubMed ID: 2413312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of acute myocardial ischemia in rabbit hearts by nafazatrom.
    Fiedler VB
    J Cardiovasc Pharmacol; 1984; 6(2):318-24. PubMed ID: 6200722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of nafazatrom to reduce infarct size and arrhythmias in a porcine model of acute coronary occlusion.
    Fiedler VB
    Eur J Pharmacol; 1985 Aug; 114(2):189-95. PubMed ID: 3930268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction.
    O'Neill PG; Charlat ML; Kim HS; Pocius J; Michael LH; Hartley CJ; Zhu WX; Roberts R; Bolli R
    Cardiovasc Res; 1987 Oct; 21(10):755-60. PubMed ID: 3125975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.
    Coker SJ; Parratt JR
    J Mol Cell Cardiol; 1984 Jan; 16(1):43-52. PubMed ID: 6366241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat.
    Fiedler VB
    Eur J Pharmacol; 1983 Mar; 88(2-3):263-7. PubMed ID: 6852112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.
    Przyklenk K; Vivaldi MT; Schoen FJ; Malcolm J; Arnold O; Kloner RA
    Cardiovasc Res; 1986 Jun; 20(6):403-14. PubMed ID: 3779738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protamine inhibits coronary collateral development in a canine model of repetitive coronary occlusion.
    Kersten JR; Pagel PS; Warltier DC
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H720-8. PubMed ID: 7532374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dipyridamole on collateral flow and regional myocardial function in conscious dogs with newly developed collaterals.
    Fujita M; Mikuniya A; McKown DP; McKown MD; Franklin D
    Basic Res Cardiol; 1990; 85(2):142-52. PubMed ID: 2350328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subendocardial versus transmural myocardial infarction: relationship to the collateral circulation in canine and porcine hearts.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    Can J Physiol Pharmacol; 1982 Dec; 60(12):1700-6. PubMed ID: 7165863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inosine on ventricular regional perfusion and infarct size after coronary occlusion.
    Devous MD; Jones CE
    Cardiology; 1979; 64(3):149-61. PubMed ID: 445523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.
    Przyklenk K; Bauer B; Ovize M; Kloner RA; Whittaker P
    Circulation; 1993 Mar; 87(3):893-9. PubMed ID: 7680290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem.
    Farber NE; Gross GJ
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial blood flow and ventricular function in dependence on the size of myocardial infarct].
    Wirth RH; Finke R; Mittmann U; Müller JH; Opherk D; Schmier J
    Langenbecks Arch Chir; 1976; Suppl():140-3. PubMed ID: 1031788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.